TecnoCampus Foundation
eCampus
University Business
eCampus

What are you looking for?
TecnoCampus research groups

Presentation

"Let food be thy medicine, and food be thy medicine" – Hippocrates

This famous phrase from the father of modern medicine already recognized, more than 2.000 years ago, the essential connection between nutrition and health. Today, this link is more relevant than ever. At the GIHDiNuC group, we delve deeper into this relationship through scientific research, with the aim of contributing to individual and collective well-being, as well as to the development of a healthier and more sustainable food system.

El Research Group in Hypoxia, Dietetics, Nutrition and Kinanthropometry   in Human Nutrition, Dietetics and Applied Health Sciences (GIHDiNuC) is directly linked to Degree in Human Nutrition and DieteticsThis is a multidisciplinary group that works on the generation and transfer of scientific knowledge oriented towards improving public health, collective well-being and disease prevention through research in nutrition, dietetics and related sciences.

The GIHDiNuC develops excellent basic and applied research, and promotes the incorporation of innovation, new technologies and quality teaching as strategic tools to respond to current challenges in the fields of health, food and sustainability.

Main objectives

 - Generate relevant scientific knowledge in human nutrition and dietetics.

 - Transfer this knowledge to society, health professionals and the productive fabric.

 - Promote the use of new technologies applied to nutrition and dietary personalization.

 - Contribute to the achievement of Sustainable Development Goals (SDGs), especially with regard to health, food safety and well-being.

 - Develop innovative teaching methodologies in the field of nutrition to integrate them into university education.

Impact and transfer

The group maintains a strong commitment to the knowledge transfer to society, the promotion of healthy food policies, the design of educational strategies for the improvement of nutritional habits and collaboration with agents in the health, food and education sectors.

GIHDiNuC research also responds to the need to personalize nutritional interventions, prevent non-communicable diseases i promote active and healthy aging, with the aim of reducing the healthcare burden and improving the population's quality of life.

Commitment to sustainability and the global agenda

The group works in alignment with the guidelines of the2030 Agenda and with reference reports such as theEAT-Lancet and theUnited Nations Food Security Report, which highlight the need to move towards sustainable, safe and fair food systems.

Areas of research

 

  • Diet and hypoxia tolerance in sports apnea
  • Intestinal health in high-performance athletes
  • Aging, fragility and nutrition
  • Infectious diseases and nutrition
  • Change in behavior and eating habits: nutritional education
  • Technology and innovation in nutrition: new foods

Group members

Group coordinator: Dr. Ishar Dalmau Santamaria

Dr. Alicia Costa Izurdiaga

Dr. Alba Vidal Torres

Dr. Eduardo Domínguez Sala

   CONTACTAR

 

Dr. Silvia Roure Diez

Dr. Marta Sánchez González

Dr. Eduardo Valenciano Mendoza

Dr. Núria Llorens Barbara

Dr. Jordi Sarola Gassiot

Mrs. Núria Mallén Esplugas

Mr. Raúl Reyes Caballero

Mr. Marcos Aguayo Mora

Mrs. Mireia Roda Cholbi

Mr. Quim Rosales Rafel

   CONTACTAR

Dr. Francesc Alòs Colomer

(Collaborating researcher)

Objeto de investigación orcid identificador de objeto ... 0000-0002-8350-062X

   CONTACTAR

Dr. Marta López Viñals

   CONTACTAR 

Mrs. Carla Estany Quera

(Collaborating researcher)

CONTACTAR

Dr. Mohamed Abdelsalam

Dr. María Marhuenda Muñoz

Areas of research

Study of the effects of nutrition on the processes of hypoxia and hypercapnia in static sports apnea


Responsible: Dr. Ishar Dalmau Santamaria


Goals:
-Describe the eating habits of adult competitive freedivers of both sexes.
-Describe the changes in oxygen and carbon dioxide saturation produced by the ketogenic diet in both sexes.
-Describe the changes in oxygen and carbon dioxide saturation produced by a vegan diet in both sexes.
-Analyze the correlation between body composition, diet and tolerance to asphyxia in both sexes.
-Analyze the biochemical changes produced according to the type of food.


Intestinal health in high-performance athletes


Responsible: Dr. Alicia Costa Izurdiaga

Goals:
-
Typically, to improve performance and recover faster, athletes are advised to eat more often than usual and consume larger doses of simple carbohydrates, during and after exercise. In addition, ergonutural supplements for athletes contain a large amount of food additives (artificial sweeteners, emulsifiers, acidity regulators, preservatives and salts), which could be harmful to the intestinal microbiota and alter intestinal permeability. On the other hand, intense exercise can cause an increase in intestinal permeability, potentially allowing microorganisms present in the intestinal microbiota to pass into the bloodstream, which causes an inflammatory response, among others, that will limit athletic performance. In clinical practice, gastrointestinal conditions are an important cause of low performance and abandonment during endurance tests. These complications are directly related to the loss of intestinal balance, mainly linked to microbiota dysbiosis and leaky gut. Studying the intestinal microbiome, the integrity of intestinal epithelia, and the intestinal secretion of hormones and peptides may help to better understand the symptoms of gastrointestinal discomfort in athletes.

Aging, fragility and nutrition


Who's in charge?: Dr. Alba Vidal Torres
Goal: The creation of a research group on aging and nutrition is highly relevant due to several interrelated factors that impact public health, quality of life and well-being of the elderly. Some key justifications are detailed below:


-Increase in the aging population
-Relationship between nutrition and healthy aging.
-Prevention of chronic diseases and complications.
-Comprehensive approach to aging.
-Innovation in the formulation of specific foods and supplements.
-Improvement of quality of life.
-Fragility and nutrition.


Infectious diseases and nutrition


Head of: Dr. Sílvia Roure Díez


Goal:
-The relationship between nutrition and infectious diseases is a topic of growing relevance in global public health. Several studies have shown that the nutritional status of a population directly affects the immune response to infections, which in turn influences morbidity, mortality and the evolution of infectious diseases. Therefore, a line of research that explores this connection is presented as fundamental to comprehensively addressing public health challenges.


Change in behavior and eating habits


Responsible: Dr. Eduardo Valenciano Mendoza


Goals:
-Psychological processes involved in eating behavior.

-Promote the change of eating habits from the perspective of transactional analysis (psychological theory of communication and personality). This approach allows us to delve deeper into the emotional and social dynamics that can slow down or favor this process, emphasizing the importance of understanding the psychological motivations that influence eating behaviors to ensure long-term success.

Novel foods: research into the use of insects and other arthropods in human nutrition


Responsible: Dr. Marta Sánchez González


Goal:
-Establishing a line of research on the use of insects as food not only addresses issues of environmental sustainability, waste reduction, food production and nutrition, but also promotes innovation in food and diversity in our diets, which is essential for a safer and more sustainable food future.


-Allergies and intolerances to new foods. The relationship and similarity of arthropods to other foods such as seafood means that they may be susceptible to causing immune reactions.


-New foods and sports performance. It is being demonstrated that the micronutrient density of insect meals can provide micronutrients that are often deficient in modern diets. It is necessary to investigate whether they can be a potential product for sports performance.

Funded competitive projects

1. Project title: Auritest. This project aims to evaluate whether non-invasive stimulation of the auricle can contribute to reducing stress and anxiety in university students during exam time. Through neuromodulation techniques, the aim is to provide a safe and effective alternative to improve the emotional well-being of students.
Period: 05/2024-07/2024.
 

2. Project Title: Treatment of post-stroke oropharyngeal dysphagia with paired stimulation through peripheral TRVP1 agonists and non-invasive brain stimulation.
Funding entity: ISCIII- Independent Clinical Research Projects.
Period: 01/2021-12/2024.

3. Project Title: Effectiveness and cost-effectiveness of Improving clinicians' diagnostic and communication skills on Antibiotic prescribing Appropriateness in patients with acute Cough in primary care in CATalonia.
Promoter entitya: TV3 Marathon Foundation.
Period: 10/11/2018-31/01/2023.
 

4. Project Title: Treatment of post-stroke oropharyngeal dysphagia with paired stimulation through peripheral TRVP1 agonists and non-invasive brain stimulation.
Funding entity: ISCIII- Independent Clinical Research Projects.
Period: 01/2021-12/2024.
 

5. Project Title: TinyBrains. European Project. Horizon 2020. Project approved by the CEIC.
Promoting entity: Saint John of God Hospital CMCiB.
Period: 2022.
 

6. Project Title: Epidemiological, clinical and diagnostic characteristics of patients with cryptosporidium infection.
Promoting entity: LUMN-Microbiology.
CEIC registration code: PI-22-282.
Period: 2022.
 

7. Project Title: Diagnostic study on a rapid immunochromatographic test for schistosomiasis in a non-endemic country.
Promoting entity FLS Foundation for the Fight against AIDS, Infectious Diseases and the Promotion of Health and Science.
CEIC registration code: PI-22-188.
Period: 2022.
 

8. Project Title: Functional unit for the comprehensive management of infection in immunocompromised patients with special mention of prevention.
Promoting entity: A. Peris Alonso (Infectious Diseases Service- HUGTiP).
CEIC registration code: PI-22-134.
Period: 2022.
 

9. Project Title: Diagnostic study on a rapid immunochromatographic test for schistosomiasis in a non-endemic country
Promoting entity: HGTP
Period: 2022.
 

10. Project Title: Community screening of schistosomiasis in the Metropolitan North SCHISTO STOP
Promoting entity: North Metropolitan Area-ICS
Period: 2022.

11. Project Title: Evaluation of the VIDAS® TB-IGRA and QuantiFERON®-TB Gold test for the diagnosis of tuberculosis infection.
Promoting entity: HGTP
Period: 2022.
 

12. Project Title: Implementing a systemic screening for TB disease in high-risk groups in the Barcelona area (SYS-TB-S).
Promoting entity: Public Health Agency.
CEIC registration code: PI-22-067.
Period: 2022.
 

13. Project Title: Evaluation of the VIDAS® TB-IGRA and QuantiFERON®-TB Gold test for the diagnosis of tuberculosis infection.
Promoting entity: Clinical Laboratory of the Metropolitan North (LCMN).
CEIC registration code: PI-21-325.
Period: 2021.
 

14. Project Title: Sit less and move more at work: Impact of an mHealth program on control.
Funding entity: FIS Call AES 2017 (File PI17/01788). Carlos III Health Institute.
Period: 2018 - 2021.
 

15. Project Title: Evaluation of the efficacy and safety of ivermectin in a single dose for the treatment of uncomplicated strongyloidiasis in immunocompromised patients.
Promoting entity: Vall d'Hebron University Hospital Foundation-Research Institute (VHIR).
CEIC registration code: PI-21-190.
Period: 2021.
 

16. Project Title: Intensified community epidemiological investigation of SARS-COVID-19 cases in a context of moderate transmission.
Promoting entity: PROSICS MetroNord.
CEIC registration code: PI-20-228.
Period: 2021.
 

17. Project Title: IVER-303 clinical trial.
Promoting entity: HGTP
Period: 2021.
 

18. Project Title: Design of an integrative tuberculosis disease staging algorithm to improve patient management at the healthcare level (STAGE-TB).
Promoting entity: HGTP.
Period: 2021.

19. Project Title: Clinical correlates and treatment outcome among sports bettors: a systematic review.
Funding entity: International project funded by the International Council on Responsible Gambling (ICRG) (United States)
Period: 2020-2021
 

20. Project Title: Diagnosis and innovative treatment of frailty and oropharyngeal dysphagia: for healthy and autonomous aging.
Funding entity: Territorial specialization and competitiveness projects (PECT) within the framework of RIS3CAT and the FEDER Catalonia Operational Program 2014-2020.
Period: 2020.
 

21. Project Title: PECT- Territorial Specialization and Competitiveness Projects - RIS3CAT and ERDF Catalonia Operational Program 2014-2020.
Funding entity: Maresme Health Consortium.
Period: 2020.

 

22. Project Title: Study INSIGHT of Genomics.
Promoting entity: University of Minnesota (UMN).
CEIC registration code: PI-20-319.
Period: 2020.
 

23. Project Title: International observational study in outpatients with SARS-CoV-2 infection.
Promoting entity: University of Minnesota (UMN).
CEIC registration code: PI-20-309.
Period: 2020.
 

24. Project Title: Cost-effectiveness of a community intervention versus a strategy based on the health system to promote the prevention, diagnosis and treatment of hepatitis B and C in immigrants in Catalonia (HepBC-link).
Promoting entity: E. Martró Català (Microbiology Service - HUGTiP).
CEIC registration code: PI-19-268.
Period: 2020.
 

25. Project Title: Multicenter, adaptive, blind, randomized, safety and efficacy controlled clinical trial of investigational therapy for the treatment of COVID-19 in hospitalized adults - Version for European Union/United Kingdom centers.
Promoting entity: University of Minnesota.
CEIC registration code: AC-20-034-HGT-CEIM.
Period: 2020.

26. Project Title: Multicenter, adaptive, randomized, controlled and blind trial of safety and efficacy of investigational therapies for hospitalized patients with COVID-19.
Promoting entity: Regents of the University of Minnesota.
CEIC registration code: AC-20-083-HGT-CEIM.
Period: 2020.
 

27. Project Title: International, multicenter, adaptive, double-blind, randomized, placebo-controlled clinical trial to evaluate the safety, tolerability and efficacy of Intravenous Anti-C Hyperimmune Immunoglobulin.
Promoting entity: Regents of the University of Minnesota.
CEIC registration code: AC-20-111-HGT-CEIM
Period: 2020.
 

28. Project Title: Multicenter, phase III, double-blind, parallel, randomized trial to evaluate the efficacy and safety of an early administration of Ivermectin for three consecutive days to prevent hospitalization related to SARS-Cov2 (COV-19) in adults over 50 years old.
Promoting entity: Chemo Research SL
CEIC registration code: AC-20-114-HGT
Period: 2020.
 

29. Project Title: Modeling Neuron-glia networks into a drug discovery platform for Pain Efficacious treatments (NGN-PET).
Funding entity: European Commission.
Period: from 01/01/2019 to 01/02/2020.
 

30. Project Title: A systematic and universal Artificial Intelligence method for oropharyngeal dysphagia (OD) screening to prevent short-term and long-term nutritional and respiratory complications in COVID-19 patients admitted in General Hospitals: How to increase the diagnosis of OD and reduce complications with risk management.
Funding entity: Agency for Healthcare Quality and Evaluation of Catalonia (AQuAS)/ PADRIS/ Generalitat of Catalonia.
Period: 2019.
 

31. Project Title: Usefulness of the Zika virus neutralization test in the follow-up of pregnant women from endemic areas.
Promoting entity: International Health Unit-Santa Coloma de Gramenet.
CEIC registration code: PI-19-166.
Period: 2019.

 

32. Title of the project: Evaluation of the effectiveness of an Optimal-Massive Intervention in older patients with oropharyngeal dysphagia.
Funding entity: Nutricia Research.
Duration: since 2020.

Scientific production

1.  Roure S, Vallès X, Pérez-Quílez O, López-Muñoz I, Chamorro A, Abad E, Valerio L, Soldevila L, Gorriz E, Herena D, Pedregal EF, España S, Serra C, Cera R, Rodríguez AM, Serrano L, Falguera G, Hegazy AHA, Fernández-Rivas G, Miralles C, Conde C, Montero-Alia JJ, Miranda-Sánchez J, Llibre JM, Isnard M, Bonet JM, Estrada O, Prat N, Clotet B; Schisto-Stop study group. Female genitourinary schistosomiasis-related symptoms in long-term sub-Saharan African migrants in Europe: a prospective population-based study. J Travel Med. 2024 Aug 3;31(6):taae035. doi:10.1093/jtm/taae035.

2. Roure S, Vallès X, Pérez-Quílez O, López-Muñoz I, Valerio L, Soldevila L, Chamorro A, Abad E, Hegazy AHA, Fernández-Rivas G, Gorriz E, Herena D, Fernández-Pedregal E, José AS, España-Cueto S, Paredes R, Miranda-Sánchez J, Miralles MC, Conde C, Montero JJ, Núñez-Andrés MA, Llibre JM, Isnard M, Bonet JM, Estrada O, Prat N, Clotet B. Morbidity burden of imported chronic schistosomiasis among West African migrants. J Infect. 2024 Oct;89(4):106234. doi:10.1016/j.jinf.2024.106234.

3. Roure S, Vallès X, Pérez-Quílez O, López-Muñoz I, Chamorro A, Abad E, Valerio L, Soldevila L, España S, Hegazy AHA, Fernández-Rivas G, Gorriz E, Herena D, Oliveira M, Miralles MC, Conde C, Montero-Alia JJ, Fernández-Pedregal E, Miranda-Sánchez J, Llibre JM, Isnard M, Bonet JM, Estrada O, Prat N, Clotet B. Male genitourinary schistosomiasis-related symptoms among long-term Western African migrants in Spain: a prospective population-based screening study. Infectious Diseases of Poverty. 2024 Mar 7;13(1):23. doi:10.1186/s40249-024-01190-8.


4. Martínez-Arias A, Valerio L, Vallès X, Roure-Díez S, Langa LS; Primary Health Mpox Study Group; Pedregal ÈF, Rodríguez ÀH, Isnard-Blanchard M, Simó JMB, Gil NP, Cirera A, Clotet B, Gené Tous E. Mpox case finding: Evaluation of a Primary Care detection program in the Northern Metropolitan area from Barcelona (Spain). Aten Primary School 2024 Sep 24;57(3):103089. doi:10.1016/j.aprim.2024.103089.

5. Vidal-Delso M, Fortuny M, González-González L, Pèlach A, Soldevila L, Roure-Díez S, Mañosa M, Domènech E. Strongyloides stercolaris hyperinfection syndrome in ulcerative colitis treated with corticotherapy: The importance of strongyloides screening. Gastroenterol Hepatol. 2024 Jul 9:502230. doi:10.1016/j.gastrohep.2024.502230.

6. Romero-Tamarit A, Vallès X, Munar-García M, Espinosa-Pereiro J, Saborit N, Tortola MT, Stojanovic Z, Roure S, Antuori A, Cardona PJ, Soriano-Arandes A, Martin-Nalda A, Espiau M, de Souza-Galvão ML, Jiménez MÁ, Noguera-Julian A, Molina I, Casas X, Domínguez-Álvarez M, Jové N, Gogichadze N, Fonseca K, Arias L, Millet JP, Sánchez-Montalvá A, Vilaplana C. A longitudinal prospective study of active tuberculosis in a Western European setting: insights and findings. Infection. 2024 Apr;52(2):611-623. doi:10.1007/s15010-024-02184-2.

7. Alòs F, Aldon Mínguez D, Cardenas Ramos M, Cancio-Trujillo JM, Cánovas Zaldúa Y, Puig-Ribera A. Mobile health in primary care. New challenges in the development of solutions to promote physical activity and well-being. 2024. Aten primary; 56-8:102900.

8. Cánovas Zaldúa Y, Alòs F, Costa Mur M, Alarcón Belmonte I, Feijoo Rodríguez V, Vidal-Alaball J. Analysis of the interruptions generated by the use of smartphones among Primary Care Health professionals. Aten Primary School 2024 Jan 16; 56(4):102855. doi:10.1016/j.aprim.2023.102855.

9. Valenciano-Mendoza E, Mora-Maltas B, Mestre-Bach G., Munguia L, Richard, J., Derevensky JL., Potenza MN, Jimenez-Murcia S. Clinical correlates of sports betting: a systematic review. J Gambl Stud Studies. 2023; 1:46 a.m. doi:10.1007/s10899-023-10196-0.

10. Vidal-Torres A, Fernández-Pastor B, Garcia M, Ayet E, Cabot A, Burgueño J, Monroy X, Aubel B, Codony X, Romero L, Pascual R, Serafini MT, Encina G, Almansa C, Zamanillo D, Merlos M, Vela JM. Bispecific sigma-1 receptor antagonism and mu-opioid receptor partial agonism: WLB-73502, an analgesic with improved efficacy and safety profile compared to strong opioids. Acta Pharmaceutica Sinica B. 2023 Sep25; Epub. doi:10.1016/j.apsb.2022.09.018.

11. Mateu L, Tebe C, Loste C, Santos JR, Lladós G, López C, España-Cueto S, Toledo R, Font M, Chamorro A, Muñoz-López F, Nevot M, Vallejo N, Teis A, Puig J, Fumaz CR, Muñoz-Moreno JA, Prats A, Estany-Quera C, Coll-Fernández R, Herrero C, Casares P, Garcia A, Clotet B, Paredes R, Massanella M.. Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study. Lancet Reg Health Eur. 2023 Sep 5;33:100724. doi:10.1016/j.lanepe.2023.100724.

12. Alòs F, Colomer MA, Bort.Puig J, Martin-Cantera C, Minaya A, Saigí I, Sitjar-Suñer M, Puig-Ribera A. Impact of a primary care-based mobile health intervention to 'sit less and move more' on glycemic control, HbA1c and cardiovascular risk factors in office employees with type 2 diabetes: A randomized controlled trial. Journal of Medical Internet Research. 2023; 46786. doi: 10.2196/preprints.46786.

13. Roure S, López F, Oliva I, Pérez-Quílez O, March O, Chamorro A, Abad E, Muñoz IL, Castillo A, Soldevila L, Valerio L, Lozano M, Masnou H, Oliveira M, Cañas L, Gibrat M, Chuecos M, Montero JJ, Colmenares K, Falguera G, Bonet JM, Isnard M, Prat N, Estrada O, Clotet B, Vallès X. Schistosomiasis screening in non-endemic countries from a cost perspective: Knowledge gaps and research priorities. The case of African long-term residents in a Metropolitan Area, Spain. PLoS Negl Too Dis. 2023 Apr 4;17(4):e0011221. doi:10.1371/journal.pntd.0011221.

14. Martínez-Arias A, Valerio LL, Roure-Díez S, Ferbánfez-Rivas G, Rivaya B, Pérez-Olmeda MT, Soldevila-Langa L, Parrón I, Clotet-Sala B, Vallès X, Rodrigo C. Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post-delivery follow-up analysis (2016-2022). Birth Defects Res. 2023 Oct 15;115(17):1646-1657. doi:10.1002/bdr2.2236.

15. Puig I, Gea M, Núñez F, Ispierto L, Grau-López L, Roure S, Lozano M, Lucente G, Vilas D. Dystonic head tremor secondary to neurocysticercosis. Neurology (Engl Ed). 2023 Apr;38(3):226-227. doi:10.1016/j.nrleng.2022.03.006.

16. Campos-Ruiz, M, Flamarich C, Fernández-Navarro A, Roure S, Martin L, Pillado P, Cardona Pere-Joan, Fernández-Rivas G. Clinical performance of lateral flow assay fpr Cryptosporidium spp. Diagnosis. 2023 Jul 29;11(8). doi:10.3390/biomedicines11082140.

17. Martínez-Arias A, Valerio L, Roure-Díez S, Fernández-Rivas G, Rivaya B, Pérez-Olmeda MT, Soldevila-Langa L, Parrón I, Clotet-Sala B, Vallès X, Rodrigo C. Zika virus screening during pregnancy: Results and lessons learned from a screening program and a post-delivery follow-up analysis (2016-2022). Birth Defects Res. 2023 Oct 15;115(17):1646-1657. doi: 10.1002/bdr2.2236.

18. Roure S, Vallès X, Sopena N, Benítez RM, Reynaga EA, Bracke C, Loste C, Mateu L, Antuori A, Baena T, Portela G, Llussà J, Flamarich C, Soldevila L, Tenesa M, Pérez R, Plasencia E, Bechini J, Pedro-Botet ML, Clotet B, Vilaplana C. Disseminated tuberculosis and diagnosis delay during the COVID-19 era in a Western European country: a case series analysis. Front Public Health. 2023 May 18;11:1175482. doi: 10.3389/fpubh.2023.1175482. Erratum in: Front Public Health. 2023 Jun 28;11:1236874. doi:10.3389/fpubh.2023.1236874.

19. Negredo E, Loste C, Puig J, Echeverría P, Fumaz CR, Muñoz-Moreno JA, Lemos B, Martínez A, Tamayo F, Saiz M, Estany C, Matarrodona M, Bonjoch A, Blanco N, Satorra P, Clotet B. Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years: a comparative cohort study (Over50 cohort). AIDS Care. 2022 Feb;34(2):155-162. doi:10.1080/09540121.2021.1998314.

20. Cañizo Vázquez D, Hadley SM, Pérez Ordóñez M, Lopez-Abad M, Valls A, López Viñals M, Moscoso BA; Fernandez SB, Camprubí-Camprubí M, Sanchez-de-Toledo J. Oxidative stress and indicators of brain damage following pediatric heart surgery. Antioxidants (Basel). 2022 Feb 28;11(3):489. doi: 10.3390/antiox11030489.

21. Etxandi M, Baenas I, Mora-Maltas B, Granero R, Fernandez-Aranda F, Tovar S, Sole-Morata N, Lucas I, Casado S, Gomez-Pena M, Moragas L, Pino-Gutierrez AD, Codina E, Valenciano-Mendoza E, Potenza MN, Dieguez C, Jimenez-Murcia S. Are signals regulating energy homeostasis related to neuropsychological and clinical features of gambling disorder? A Case-Control Study. nutrients 2022; 14(23):5084. doi:10.3390/nu14235084.

22. Valenciano-Mendoza E, Fernandez-Aranda F, Granero R, Vintro-Alcaraz C, Mora-Maltas B, Valero-Solis S, Sanchez I, Toro JJ, Gomez-Pena M, Moragas L, Jimenez-Murcia S. Common and differential risk factors behind suicidal behavior in patients with impulsivity-related disorders: The case of bulimic spectrum eating disorders and gambling disorder. Journal of Behavioral Addictions. 2022; 10.1556/2006.2022.00072. doi:10.1556/2006.2022.00072.

23. Estevez A, Macia L, Lopez-Gonzalez H, Momene J, Jauregui P, Etxaburu N, Granero R, Fernandez-Aranda F, Mestre-Bach G, Vintro-Alcaraz C, Munguia L, Baenas I, Mena-Moreno T, Mora-Maltas B, Valenciano-Mendoza E, Jimenez-Murcia S. Cyberbullying and gambling disorder: associations with emotion regulation and coping strategies. J Gamble Stud. 2022; 10.1007/s10899-022-10160-4. doi:10.1007/s10899-022-10160-4.

24. Munguia L, Jimenez-Murcia S, Valenciano-Mendoza E, Granero R, Gaspar-Perez A, Guzman-Saldana R, Sanchez-Gutierrez M, Fazia G, Galvez L, Gearhardt AN, Fernandez-Aranda F. Risk patterns in food addiction: a Mexican population approach. Eating and Weight Disorders. 2022; 27(3):1077-1087. doi:10.1007/s40519-021-01240-2.

25. Vintro-Alcaraz C, Mestre-Bach G, Granero R, Caravaca E, Gomez-Pen, M, Moragas L, Baenas I, Del Pino-Gutierrez A, Valero-Solis S, Lara-Huallipe M, Mora-Maltas B, Valenciano-Mendoza E, Guillen-Guzman E, Codina E, Menchon JM, Fernandez-Aranda F, Jimenez-Murcia S. Exploring the association between gambling-related offenses, substance use, psychiatric comorbidities, and treatment outcome. Journal of Clinical Medicine. 2022; 11(16):4669. doi:10.3390/jcm11164669.

26. Mestre-Bach G, Granero R, Mora-Maltas B, Valenciano-Mendoza E, Mungui L, Potenza MN, Derevensky JL, Richard J, Fernandez-Aranda F, Menchon JM, Jimenez-Murcia S. Sports-betting-related gambling disorder: clinical features and correlates of cognitive behavioral therapy outcomes. Addict Behav. 2022 Oct; 133:107371. doi:10.1016/j.addbeh.2022.107371.

27. Viñas Beumala P, Bolívar Prados M, Tomsen Ferrer N, Costa Izurdiaga A, Marin S; Riera Nuñez S, Barcons N, Clave Civit P. The hydration status of adult patients with oropharyngeal dysphagia and the effect of thickened fluid therapy on fluid intake and hydration: results of two parallel systematic and scoping reviews. nutrients 2022 Jun 16; 14(12):2497. doi:10.3390/nu14122497.

28. Martín Martinez A, Ortega O, Viñas P, Arreola V, Nascimiento W, Costa Izurdiaga A, Riera Nuñez S, Alarcón C, Clavé Civit P. COVID-19 is associated with oropharyngeal dysphagia and malnutrition in hospitalized patients during the spring 2020 wave of the pandemic. Clin Nutri 2022 Dec; 41(12):2996-3006.

29. Alòs F, Colomer MA, Martin-Cantera C, Solís-Muñoz M, Bort-Roig J, Sigi I, Chirveches-Pérez E, Solà-Gonfaus M, Molina-Aragonés JM, Puig-Ribera A. Effectiveness of a healthcare-based mobile intervention on sedentary patterns, physical activity, mental well-being and clinical and productivity outcomes in office employees with type 2 diabetes: study protocol for a randomized controlled trial. BMC Public Health. 2022; 22:1269. doi:10.1186/s12889-022-13676-x.

30. Sitjar-Suñer M, Suñer-Soler R, Bertran-Noguer C, Masià-Plana A, Romero-Marull N, Reig-Garcia G, Alòs F, Patiño-Masó J. 2022. Mortality and Quality of Life with Chronic Kidney Disease: A Five-Year Cohort Study with a Sample Initially Receiving Peritoneal Dialysis. Healthcare. MDPI. 2022; 10-2144.

31. Alòs Colomer F, Colomer Cugat MA, Bort-Roig J, Chirveches-Pérez E, Cánovas Zaldúa Y, Martín-Cantera C, Franch-Nadal J, Puig-Ribera A. Differences in free-living patterns of sedentary behavior between office employees with diabetes and office employees without diabetes: a principal component analysis for clinical practice. Environmental Research and Public Health. MDPI. 2022; 19-12245.

32. Alòs F, Cánovas Zaldúa Y, Feijóo Rodríguez MV, Del Val Garcia JL, Sánchez-Callejas A, Colomer MA. Does Influenza Vaccination Reduce the Risk of Contracting COVID-19? Journal of Clinical Medicine. MDPI. 2022; 11-5297.

33. Roure S, Pérez-Quílez O, Vallès X, Valerio L, López-Muñoz I, Soldevila L, Torrella A, Fernández-Rivas G, Chamorro A, Clotet B. Schistosomiasis Among Female Migrants in Non-endemic Countries: Neglected Among the Neglected? A Pilot Study. Front Public Health. 2022 Mar 9;10:778110. doi:10.3389/fpubh.2022.778110.

34. Roure S, Pérez-Quílez O, Vallès X, Valerio L, Fernández-Rivas G, Rivaya B, López-Muñoz I, Soldevila L, Villanova X, Paredes R, Pedro-Botet ML, Videla S, Clotet B. A simple new screening tool for diagnosing imported schistosomiasis. Public Health Pract (Oxf). 2022 Mar 18;3:100245. doi:10.1016/j.puhip.2022.100245.

35. Salas-Coronas J, Pérez Pérez A, Roure S, Sánchez Peinador C, Santos Larrégola L, Arranz Izquierdo J, Bocanegra C, García López Hortelano M, García Vázquez E, Moza Moriñigo H, Azkune Galparsoro H. Consensus document for the management of schistosomiasis in primary care. Aten Primary School 2022 Aug;54(8):102408. Spanish. doi:10.1016/j.aprim.2022.102408.

36. López-Muñoz I, Torrella A, Pérez-Quílez O, Castillo-Zuza A, Martró E, Bordoy AE, Saludes V, Blanco I, Soldevila L, Estrada O, Valerio L, Roure S, Vallès X. SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain. Emerg Infect Dis. 2022 Oct;28(10):1999-2008. doi:10.3201/eid2810.220494.

37. Bosch-Nicolau P, Salvador F, Sánchez-Montalvá A, Franco-Jarava C, Arrese-Muñoz I, Sulleiro E, Roure S, Valerio L, Oliveira-Souto I, Serre-Delcor N, Pou D, Treviño B, Aznar ML, Espinosa-Pereiro J, Molina I. Association of HLA-B35 and moderate or severe cutaneous reactions secondary to benznidazole treatment in chronic chagas disease. Clin Microbiol Infect. 2022 Jun;28(6):881.e1-881.e5. doi:10.1016/j.cmi.2021.11.021.

38. Colomer MA, Margalida A, Alòs F, Oliva-Vidal P, Vilella A, Fraile L. Modeling of vaccination and contact tracing as tools to control the covid-19 outbreak in Spain. Vaccines. MDPI. 2021; 9-4:386-386.

39. Colomer MA, Margalida A, Alòs F, Oliva-Vidal P, Vilella A, Fraile L. Modeling the SARS-CoV-2 outbreak: Assessing the usefulness of protective measures to reduce the pandemic at population level. Science of the Total Environment (Stoten). 2021; 789-147816. doi:10.1016/j.scitotenv.2021.147816.

40. Puig J, Echeverría P, Lluch T, Herms J, Estany C, Bonjoch A, Ornelas A, París D, Loste C, Sarquella M, Clotet B, Negredo E. A Specific Mobile Health Application for Older HIV-Infected Patients: Usability and Patient's Satisfaction. Telemed JE Health. 2021 Apr;27(4):432-440 doi:10.1089/tmj.2020.0098.

41. Loste C, Moltó J, Pérez-Álvarez N, Puig J, Echeverría P, Bonjoch A, Fumaz CR, Lemos B, Estany C, Clotet B, Negredo E. Potential prescribing issues among older HIV-infected subjects in a Mediterranean cohort: Does the current prevalence give cause for concern? Br J Clin Pharmacol. 2021; 87:1310-1317 doi:10.1111/bcp.14513.
 

42. Mestre-Bach G, Valenciano-Mendoza E, Mora-Maltas B, Fernandez-Aranda, Jimenez-Murcia S. Gambling addiction: myth or reality? Analyzing the scientific evidence on gambling disorder. Method Science Studies Journal. 2021. doi:10.7203/metode.12.18490.
 

43. Baenas I, Etxandi M, Codina E, Granero R, Fernandez-Aranda F, Gomez-Pena M, Moragas L, Rivas S, Potenza MN, Hakansson A, Del Pino-Gutierrez A, Mora-Maltas B, Valenciano-Mendoza E, Menchon JM, Jimenez-Murcia S. Does confinement affect treatment dropout rates in patients with gambling disorder? A nine-month observational study. Frontiers in psychology. 2021; 12:761802. doi:10.3389/fpsyg.2021.761802.
 

44. Lara-Huallipe ML., Granero R, Fernandez-Aranda F, Gomez-Pena M, Moragas L, Del Pino-Gutierrez A, Valenciano-Mendoza E, Mora-Maltas B, Baenas I, Etxandi M, Menchon JM, Jimenez-Murcia S. Clustering treatment outcomes in women with gambling disorder. J Gamble Stud. 2021; 10.1007/s10899-021-10092-5. doi:10.1007/s10899-021-10092-5.

45. Valenciano-Mendoza E, Fernandez-Aranda F, Granero R, Gomez-Pena M, Moragas L, Mora-Maltas B, Hakansson A, Menchon JM, Jimenez-Murcia S. Prevalence of suicidal behavior and associated clinical correlates in patients with behavioral addictions. International Journal of Environmental Research and Public Health. 2021; 18(21):11085. doi:10.3390/ijerph182111085.

46. Vintro-Alcaraz C, Mestre-Bach G, Granero R, Cuquerella A, Talon-Navarro MT, Valenciano-Mendoza E, Mora-Maltas B, Del Pino-Gutierrez A, Gomez-Pena M, Moragas L, Fernandez-Aranda F, Codina E, Valero-Solis S, Guillen-Guzman E, Lara-Huallipe ML, Sole-Morata N, Jimenez-Murcia S. Identifying associated factors for illegal acts among patients with gambling disorder and ADHD. J Gamble Stud. 2021; 10.1007/s10899-021-10082-7. doi:10.1007/s10899-021-10082-7.

47. Etxandi M, Baenas I, Munguia L, Mestre-Bach G, Granero R., Gomez-Pena M, Moragas L, Del Pino-Gutierrez A, Codina E, Mora-Maltas B, Valenciano-Mendoza E, Potenza MN, Gearhardt AN, Fernandez-Aranda F, Jimenez-Murcia S. Clinical features of gambling disorder patients with and without food addiction: gender-related considerations. Journal of gambling studies 2021; 10.1007/s10899-021-10071-w. doi:10.1007/s10899-021-10071-w.

48. Valenciano-Mendoza E, Fernandez-Aranda F, Granero R, Gomez-Pena M, Moragas L, Pino-Gutierrez AD, Mora-Maltas B., Baenas I, Guillen-Guzman E, Valero-Solis S, Lara-Huallipe M. L, Codina E, Mestre-Bach G, Etxandi M, Menchon JM, Jimenez-Murcia S. Suicidal behavior in patients with gambling disorder and their response to psychological treatment: the roles of gender and gambling preference. Journal of Psychiatric Research. 2021; 143:317-326. doi:10.1016/j.jpsychires.2021.09.027.

49. Granero R, Fernandez-Aranda F, Castro-Calvo J, Billieux J, Valero-Solis S, Mora-Maltas B, Rivas-Perez S, Valenciano-Mendoza E, Del Pino-Gutierrez A, Gomez-Pena , Moragas L, Baenas I, Mena-Moreno T, Casale-Salayet G, Codina E, Gonzalez-Bueso V, Santamaria JJ, Bano M, Menchon JM, Jimenez-Murcia S. Subtyping treatment-seeking gaming disorder patients. Addictive Behaviors 2021. 123:107086. doi: 10.1016/j.addbeh.2021.107086.

50. Bano M, Mestre-Bach G, Granero R, Fernandez-Aranda F, Gomez-Pena M, Moragas L, Del Pino-Gutierrez A, Codina E, Guillen-Guzman E, Valero-Solis S, Lizbeth Lara-Huallipe M, Baenas I, Mora-Maltas B, Valenciano-Mendoza E, Sole-Morata N, Galvez-Sole L, Gonzalez-Bueso V. Jose Santamaria J, Menchon JM, Jimenez-Murcia S. Women and gambling disorder: Assessing dropouts and relapses in cognitive behavioral group therapy. Addictive Behaviors. 2021; 123:107085. doi:10.1016/j.addbeh.2021.107085.

51. Mena-Moreno T, Fernandez-Aranda F, Granero R, Munguia L, Steward T, Lopez-Gonzalez H, Del Pino-Gutierrez A, Lozano-Madrid M, Gomez-Pena M, Moragas L, Giroux I, Grall-Bronnec M, Sauvaget A, Mora-Maltas B, Valenciano-Mendoza E, Menchon JM, & Jimenez-Murcia S. A serious game to improve emotion regulation in treatment-seeking individuals with gambling disorder: a usability study. Frontiers in Psychology. 2021; 12:621953. doi:10.3389/fpsyg.2021.621953.

52. Jimenez-Murcia S, Gimenez M, Granero R, Lopez-Gonzalez H, Gomez-Pena M, Moragas L, Baenas I, Del Pino-Gutierrez A, Codina E, Mena-Moreno T, Valenciano-Mendoza E, Mora-Maltas B, Valero-Solis S, Rivas-Perez S, Guillen-Guzman E, Menchon JM, Fernandez-Aranda F. Psychopathological status and personality correlates of problem gambling severity in sports bettors undergoing treatment for gambling disorder. Journal of Behavioral Addictions. 2021; 10.1556/2006.2020.00101. doi:10.1556/2006.2020.00101.

53. Granero R, Fernandez-Aranda F, Pino-Gutierrez AD, Etxandi M, Baenas I, Gomez-Pena M, Moragas L, Valenciano-Mendoza E, Mora-Maltas B, Valero-Solis S, Codina E, Guillen-Guzman E, Lara-Huallipe M, Caravaca E, Mestre-Bach G, Menchon JM, Jimenez-Murcia S. The prevalence and characteristics of schizophrenia among individuals with gambling disorder. Journal of Psychiatric Research. 2021; 136:374–383. doi:10.1016/j.jpsychires.2021.02.025.

54. Pettorruso M, Testa G, Granero R, Martinotti G, d'Andrea G, di Giannantonio M, Fernandez-Aranda F, Mena-Moreno T, Gomez-Pena , Moragas L, Baenas I, Del Pino-Gutierrez A, Codina E., Valenciano-Mendoza E, Mora-Maltas B, Zoratto , Valero-Solis S, Guillen-Guzman E, Menchon JM, Jimenez-Murcia S. The transition time to gambling disorder: the roles that age, gambling preference and personality traits play. Addictive Behaviors. 2021; 116:106813. doi:/10.1016/j.addbeh.2020.106813.

55. Aguera Z, Riesco N, Valenciano-Mendoza E, Granero R, Sanchez I, Andreu A, Jimenez-Murcia S, Fernandez-Aranda F. Illness perception in patients with eating disorders: clinical, personality, and food addiction correlates. Eating and Weight Disorders. 2021; 26(7):2287-2300. doi:10.1007/s40519-020-01083-3.

56. Jimenez-Murcia S, Gimenez M, Granero R, Masuet-Aumatell C, Ramon JM, Aguero F, Morchon S, Moragas L, Baenas I, Del Pino-Gutierrez A, Codina E, Valenciano-Mendoza E, Mora-Maltas B, Valero-Solis S, Etxandi M, Guillen-Guzman E, Menchon JM, Fernandez-Aranda F. Gambling disorder seeking treatment patients and tobacco use in relation to clinical profiles. Addictive Behaviors. 2021; 114:106723. doi:10.1016/j.addbeh.2020.106723.

57. Mestre-Bach G, Granero R, Vintro-Alcaraz C, Juve-Segura G, Marimon-Escudero M, Rivas-Perez S, Valenciano-Mendoza E, Mora-Maltas B, Del Pino-Gutierrez A, Gomez-Pena M, Moragas L, Fernandez-Aranda F, Codina E, Mena-Moreno T, Valero-Solis S, Guillen-Guzman E, Mencho JM, Jimenez-Murcia S. Youth and gambling disorder: what about criminal behavior? Addictive Behaviors. 2021; 113:106684. doi:10.1016/j.addbeh.2020.106684.

58. Estevez A, Jauregui P, Lopez-Gonzalez H, Macia L, Lopez N, Zamora L, Onaindia J, Granero R, Mestre-Bach G, Steward T, Fernandez-Aranda , Gomez-Pena M, Moragas L, Mena-Moreno T, Lozano-Madrid M, Del Pino-Gutierrez A, Codina E, Testa G, Vintro-Alcaraz C, Aguera Z, Valenciano-Mendoza E, Jimenez-Murcia S. Exploring the predictive value of gambling motives, cognitive distortions, and materialism on problem gambling severity in adolescents and young adults. Journal of Gambling Studies. 2021; 37(2):643-661. doi:10.1007/s10899-020-0997.

59. Estevez A, Jauregui P, Lopez-Gonzalez H, Mena-Moreno T, Lozano-Madrid M, Macia L, Granero R, Mestre-Bach G, Steward T, Fernandez-Aranda F, Gomez-Pena M, Moragas L, Del Pino-Gutierrez A, Codina E, Testa G, Vintro-Alcaraz C, Aguera Z, Munguia L, Baenas I, Valenciano-Mendoza E, Jimenez-Murcia S. The severity of gambling and gambling related cognitions as predictors of emotional regulation and coping strategies in adolescents. Journal of Gambling Studies. 2021; 37(2):483-495. doi:10.1007/s10899-020-09953-2.

60. Sánchez-Montalvá A, Salinas C, Sullerio E, Salvador F, Bosch-Nicolau P, Crespillo-Andújar C, Trigo E, Roure S, Valerio L, Espinosa-Pereiro J, Molina I. Risk of Trypanosoma cruzi infection among travelers visiting friends and relatives to continental Latin America. PLoS Negl Too Dis. 2021 Jul 2;15(7):e0009528. doi:10.1371/journal.pntd.0009528.

61. Salvador F, Lucas-Dato A, Roure S, Arsuaga M, Pérez-Jacoiste A, García-Rodríguez M, Pérez-Molina JA, Buonfrate D, Saugar JM, Molina I. Effectiveness and Safety of a Single-Dose Ivermectin Treatment for Uncomplicated Strongyloidiasis in Immunosuppressed Patients (ImmunoStrong Study): The Study Protocol. Pathogens. 2021 Jun 27;10(7):812. doi:10.3390/pathogens10070812.

62. Díaz JL, Cuevas F, Oliva AI, Font D, Sarmentero MÁ, Álvarez-Bercedo P, López-Valbuena JM, Pericàs MA, Enrech R, Montero A, Yeste S, Vidal-Torres A, Álvarez I, Pérez P, Cendán CM, Cobos EJ, Vela JM, Almansa C.. Tricyclic triazoles as σ1 receptor antagonists for treating pain. Journal of Medicinal Chemistry. 2021; 64(8):5157-5170. doi:10.1021/acs.jmedchem.1c00244.

63. Soldevila L, Valerio-Sallent L, Roure S, Pérez-Quílez O, Mas MÀ, Miralles R, López-Muñoz I, Estrada O, Vallès X. Drug exposure may have a substantial influence on COVID-19 prognosis among residents of long-term care facilities: an exploratory analysis. Int J Infect Dis. 2021 Aug;109:192-194. doi:10.1016/j.ijid.2021.07.007.

64. Reynaga E, Carrillo J, Santos JR, Roure S, Mateu L, Paredes R, Clotet B, Izquierdo-Useros N, Pedro-Botet ML. Outcome of hospitalized patients with COVID-19 pneumonia treated with high-dose immunoglobulin therapy in a prospective case series. Clin Microbiol Infect. 2021 Apr;27(4):651-652. doi:10.1016/j.cmi.2020.10.010.

65. Roure S, Fernández-Rivas G, Ruf MT, Grau-López L, Guarro L, Matas L, Nickel B, Valerio L. A cluster of travelers with headache and a hidden travel companion, Angiostrongylus cantonensis: A diagnostic challenge. Travel Med Infect Dis. 2021 Nov-Dec;44:102187. doi:10.1016/j.tmaid.2021.102187.

66. Vallès X, Roure S, Valerio L, López-Muñoz I, Pérez-Quílez O, Soldevila L, Martín-Cano L, Estrada O, Palacín MD, Blanco I, Orozco J, Esquerrà A, Villanova X. SARS-CoV-2 contact tracing among disadvantaged populations during epidemic intervals should be a priority strategy: results from a pilot experiment in Barcelona. Public Health. 2021 Jun;195:132-134. doi:10.1016/j.puhe.2021.04.027.

67. Roure S, Fernández-Rivas G, Ruf MT, Grau-López L, Guarro L, Matas L, Nickel B, Valerio L. A cluster of travelers with headache and a hidden travel companion, Angiostrongylus cantonensis: A diagnostic challenge. Travel Med Infect Dis. 2021 Nov-Dec;44:102187. doi:10.1016/j.tmaid.2021.102187.

68. Mateo L, Roure S, Prior Á, Torres MCS, Subirats JL, Hermoso JAH. Multiple Primary Muscular Hydatidosis in an Immunosuppressed Patient. J Clin Rheumatol. 2021 Dec 1;27(8S):S603-S606. doi:10.1097/RHU.0000000000000954.

69. Rodríguez de la Concepción ML, Ainsua-Enrich E, Reynaga E, Ávila-Nieto C, Santos JR, Roure S, Mateu L, Paredes R, Puig J, Jimenez JM, Izquierdo-Useros N, Clotet B, Pedro-Botet ML, Carrillo J. High-dose intravenous immunoglobulins might modulate inflammation in COVID-19 patients. Life Sci Alliance. 2021 Jul 28;4(9):e202001009. doi:10.26508/lsa.202001009.

70. Valerio Sallent L, Moreno Santabarbara P, Roure Díez S. Abdominal pain secondary to neuroinvasive Angiostrongylus cantonensis; first European case. Some reflections on emerging parasitosis. Gastroenterol Hepatol. 2021 Oct;44(8):566-567. English, Spanish. doi:10.1016/j.gastrohep.2020.07.023.

71. Langa LS, Sallent LV, Roure-Díez S. Interpretation of the diagnostic tests of the COVID-19. FMC. 2021 Mar;28(3):167-173. Spanish. doi:10.1016/j.fmc.2021.01.005.

72. Prior-Español Á, Roure S, Mateo L, Martínez-Morillo M. Anemia and Eosinophilia Secondary to Strongyloides in a Patient Treated with Anti-TNF-Alpha. Rheumatol Clin (Engl Ed). 2020 Nov-Dec;16(6):508-509. English, Spanish. doi:10.1016/j.reuma.2018.11.009.

73. Valerio L, Roure Díez S, Benítez R, Fernández-Rivas G, Rivaya B, Expósito C, Saperas C, Salvador F, Clotet B. Intensified epidemiological surveillance of arbovirosis: First case of native dengue fever in Catalonia (Spain), Northern Metropolitan Area of ​​Barcelona, ​​2018-2019. Aten Primary School 2018 Jan;2019(2021):53-1. Spanish. doi:73/j.aprim.80.

74.Costa Izurdiaga A, Martín A, Arreola V, Riera S, Pizarro A, Carol C, Serras L, Clavé P. Assessment of swallowing disorders, nutritional and hydration status and oral hygiene in students with severe neurological disabilities including cerebral palsy. nutrients 2021 Jul 14; 13(7):2413. doi:10.3390/nu13072413.

75. Jimenez-Murcia S, Granero R, Gimenez M, Del Pino-Gutierrez A, Mestre-Bach G, Mena-Moreno T, Moragas L, Bano M, Sanchez-Gonzalez J, de Gracia , Baenas-Soto I, Contaldo SF, Valenciano-Mendoza E, Mora-Maltas B, Lopez-Gonzalez H, Menchon JM, Fernandez-Aranda F. Contribution of sex on the underlying mechanism of the gambling disorder severity. Scientific Reports. 2020; 10(1):18722. doi:10.1038/s41598-020-73806-6.

76. Krug, I, Granero R, Giles S, Riesco N, Aguera Z, Sanchez I, Jimenez-Murcia S, Del Pino-Gutierrez A, Codina E, Baena I, Valenciano-Mendoza E, Menchon JM, Fernandez-Aranda F. A cluster analysis of purging disorder: validation analyzes with eating disorder symptoms, general psychopathology and personality. European Eating Disorders Review: The Journal of the Eating Disorders Association. 2020; 28(6):643-656. doi:10.1002/erv.2769.

77. Estevez A, Jauregui P, Granero R, Munguia L, Lopez-Gonzalez H, Macia L, Lopez N, Momene J, Corral S, Fernandez-Aranda F, Aguera Z, Mena-Moreno T, Lozano-Madrid M, Vintro-Alcaraz C, Del Pino-Gutierrez A, Codina E, Valenciano-Mendoza E, Gomez-Pen M, Moragas L, Casale G, Jimenez-Murcia S. Buying-shopping disorder, emotion dysregulation, coping and materialism: a comparative approach with gambling patients and young people and adolescents. International Journal of Psychiatry in Clinical Practice. 2020; 24(4): 407-415. doi:10.1080/13651501.2020.1780616.

78. Granero R, Jimenez-Murcia S, Del Pino-Gutierrez A, Mora B, Valenciano-Mendoza E, Baenas-Soto I, Gomez-Pena M, Moragas L, Codina E, Lopez-Gonzalez H, Mena-Moreno T, Mestre-Bach G, Valero-Solis S, Rivas S, Aguera Z, Vintro-Alcaraz C, Lozano-Madrid M, Menchon JM, Fernandez-Aranda F. Gambling phenotypes in online sports betting. Frontiers in Psychiatry. 2020; 11:482. doi:10.3389/fpsyt.2020.00482.

79. Granero R, Fernandez-Aranda F, Valero-Solis S, Pino-Gutierrez AD, Mestre-Bach, G, Baenas I, Contaldo SF, Gomez-Pena M, Aymami N, Moragas L, Vintro , Mena-Moreno T, Valenciano-Mendoza E, Mora-Maltas B, Menchon JM, Jimenez-Murcia S. The influence of chronological age on cognitive biases and impulsivity levels in male patients with gambling disorder. Journal of Behavioral Addictions. 2020; 9(2):383-400. doi:10.1556/2006.2020.00028.

80. Granero R, Jimenez-Murcia S, Fernandez-Aranda F, Del Pino-Gutierrez A, Mena-Moreno T, Mestre-Bach G, Gomez-Pena M, Moragas L, Aymami N, Giroux I, Grall-Bronnec M, Sauvaget A, Codina E, Vintro-Alcaraz C, Lozano-Madrid , Camozzi , Aguera Z, Sanchez-Gonzalez J, Casale-Salayet G, Sanchez I, Valenciano-Mendoza E. Menchon JM. Presence of problematic and disordered gambling in older age and validation of the South Oaks Gambling Scale. PloS one. 2020. 15(5): e0233222. doi:10.1371/journal.pone.0233222.

81. Granero R, Valero-Solis S, Fernandez-Aranda F, Gomez-Pena M, Moragas L, Mena-Moreno T, Pino-Gutierrez AD, Codina E, Martin-Romera V, Casale G, Aguera Z, Baenas-Soto I, Valenciano-Mendoza E, Mora-Maltas B, Sanchez I, Lozano-Madrid M, Menchon JM, Murcia SJ. Response trajectories of gambling severity after cognitive behavioral therapy in young-adult pathological gamblers. Journal of Behavioral Addictions. 2020. 9(1):140-152. doi:10.1556/2006.2020.00008.

82. Jimenez-Murcia S, Granero R, Gimenez M, Del Pino-Gutierrez A, Mestre-Bac G., Mena-Moreno T, Moragas L, Bano , Sanchez-Gonzalez J, de Gracia M, Baenas-Soto I, Contaldo SF, Valenciano-Mendoza E, Mora-Maltas B, Lopez-Gonzalez , Menchon JM, Fernandez-Aranda F. Moderator effect of sex in the clustering of treatment-seeking patients with gambling problems. Moderierender Effekt des Geschlechts bei derClusterbildung von behandlungssuchenden Patienten mit Glucksspielproblemen. Neuropsychiatrie: Klinik, Diagnostik, Therapie und Rehabilitation: Organ der Gesellschaft Osterreichischer Nervenarzte und Psychiater. 2020; 34(3):116-129. doi:10.1007/s40211-020-00341-1.

83. Granero R, Jimenez-Murcia S, Del Pino-Gutierrez A, Mena-Moreno T, Mestre-Bach G, Gomez-Pena M, Moragas L, Aymami N, Giroux I, Grall-Bronnec M, Sauvaget A, Codina E, Vintro-Alcaraz C, Lozano-Madrid M, Camozzi M, Aguera Z, Martin-Romera V, Sanchez-Gonzalez J, Casale G, Sanchez I, Valenciano-Mendoza E, Fernandez-Aranda F. Gambling phenotypes in older adults. Journal of Gambling Studies. 2020; 36(3):809-828. doi:10.1007/s10899-019-09922-4.

84. Alcántara A, Soldevila L, Valerio L, Roure S, Pérez-Quílez O, Martinez-Cuevas O, Villanova X. Cutaneous larva migrans or the wandering invader. Description of 16 houses in the Northern Metropolitan area of ​​Barcelona. Travel Med Infect Dis. 2020 Jul-Aug;36:101545. doi:10.1016/j.tmaid.2019.101545.

85. García M, Virgili M, Alonso M, Alegret C, Farran J, Fernández B, Bordas M, Pascual R, Burgueño J, Vidal-Torres A, Fernández de Henestrosa AR, Ayet E, Merlos M, Vela JM, Plata-Salamán CR, Almansa C. Discovery of est73502, a dual μ-opioid receptor agonist and σ1 receptor antagonist clinical candidate for the treatment of pain. Journal of Medicinal Chemistry. 2020; 63(24):15508-15526. doi: 10.1021/acs.jmedchem.0c01127.

86. Díaz JL, García M, Torrens A, Caamaño AM, Enjo J, Sicre C, Lorente A, Port A, Montero A, Yeste S, Álvarez I, Martín M, Maldonado R, de la Puente B, Vidal-Torres A, Cendán CM, Vela JM, Almansa C. EST64454: a highly soluble σ1 receptor antagonist clinical candidate for pain management. Journal of Medicinal Chemistry. 2020; 63(23):14979-14988. doi:10.1021/acs.jmedchem.0c01575.

87. García M, Virgili M, Alonso M, Alegret C, Fernández B, Port A, Pascual R, Monroy X, Vidal-Torres A, Serafini MT, Vela JM, Almansa C. 4-Aryl-1-oxa-4,9-diazaspiro[5.5]undecane Derivatives as Dual μ-Opioid Receptor Agonists and σ1 Receptor Antagonists for the treatment of pain. Journal of Medicinal Chemistry. 2020; 63(5):2434-2454. doi:10.1021/acs.jmedchem.9b01256.

88. Roure S, Valerio L, Soldevila L, Salvador F, Fernández-Rivas G, Sulleiro E, Mañosa M, Sopena N, Mate JL, Clotet B. Approach to amoebic colitis: Epidemiological, clinical and diagnostic considerations in a non-endemic context (Barcelona, ​​2007-2017). PLoS One. 2019 Feb 21;14(2):e0212791. doi:10.1371/journal.pone.0212791.

89. Guillén Y, Noguera-Julian M, Rivera J, Casadellà M, Zevin AS, Rocafort M, Parera M, Rodríguez C, Arumí M, Carrillo J, Mothe B, Estany C, Coll J, Bravo I, Herrero C, Saz J, Sirera G, Torrella A, Navarro J, Crespo M, Negredo E, Brander C, Blanco J, Calle ML, Klatt NR, Clotet B, Paredes R. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019; 12(1):232-246. doi:10.1038/s41385-018-0083-7

90. Romero X, Aguera Z, Granero R, Sanchez I, Riesco N, Jimenez-Murcia S, Gisbert-Rodriguez M, Sanchez-Gonzalez J, Casale G, Baenas I, Valenciano-Mendoza E, Menchon JM, Gearhardt AN, Dieguez C, Fernandez-Aranda F. Is food addiction a predictor of treatment outcome among patients with eating disorder? European Eating Disorders Review: the Journal of the Eating Disorders Association. 2019; 27(6):700-711. doi:10.1002/erv.2705.

91. Vidal-Torres A, Fernández-Pastor B, Carceller A, Vela JM, Merlos M, Zamanillo D. Supraspinal and peripheral, but not intrathecal, σ1r blockade by s1ra enhances morphine antinociception. Frontiers in Pharmacology. 2019 Apr 24; 10:422. doi:10.3389/fphar.2019.00422.

92. Costa Izurdiaga A, Carrion S, Puig-Pey M, Juárez F, Clavé P. Triple adaptation of the Mediterranean diet: design of a meal plan for older people with oropharyngeal dysphagia based on home cooking. nutrients 2019 Feb; 11(2):425. doi:10.3390/nu11020425.

93. Juan ME, Lozano-Mena G, Sánchez-González M, Plana JM. Reduction of preneoplastic lesions induced by 1,2-dimethylhydrazine in rat colon by maslinic acid, a pentacyclic triterpene from Olea europaea L. Molecules. 2019 Apr 1;24(7):1266. doi:10.3390/molecules24071266